|
261 |
Acute electrical muscle stimulation effects on strength and anaerobic power in soccer players Enthalten in International journal of sports medicine 11.04.2025
|
|
|
262 |
“Homeopathy is not Placebo Effect” Proof of Scientific Evidence for Homeopathy by Marcus Zulian Teixeira, MD Enthalten in Homoeopathic links 10.04.2025
|
|
|
263 |
Assessing the Efficacy of Ligilactobacillus salivarius CLS0420 and Lacticaseibacillus paracasei CLPC0603 on Vaginal Well-Being in Healthy Women: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial Enthalten in Probiotics and Antimicrobial Proteins 7.4.2025: 1-13
|
|
|
264 |
Placebo response variability on health-related quality of life outcomes in irritable bowel syndrome: an arm-based network meta-analysis Enthalten in Quality of life research 25.2.2025: 1-16
|
|
|
265 |
Effects of a single dose of a betalain-rich concentrate on determinants of running performance and recovery muscle blood flow: a randomized, triple-blind, placebo-controlled, crossover trial Enthalten in European journal of applied physiology 24.2.2025: 1-8
|
|
|
266 |
Postbiotic Supplementation Increases Amino Acid Absorption from Plant-Based Meal: A Placebo-Controlled, Randomized, Double-Blind, Crossover Study Enthalten in Probiotics and Antimicrobial Proteins 24.2.2025: 1-15
|
|
|
267 |
Efficacy and safety of elobixibat in patients with chronic constipation—A randomized, multicenter, double-blind, placebo-controlled, parallel-group study from India Enthalten in Indian journal of gastroenterology 22.2.2025: 1-9
|
|
|
268 |
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial Enthalten in International journal of clinical pharmacy 20.2.2025: 1-9
|
|
|
269 |
Correction: The Effectiveness of Bromelain on Oedema, Subconjunctival Haemorrhage, and Ecchymosis After Rhinoplasty: A Randomised, Double-Blind, Placebo-Controlled Trial Enthalten in Aesthetic plastic surgery 20.2.2025: 1
|
|
|
270 |
Efficacy and safety of patiromer for hyperkalemia: a randomized, placebo-controlled phase 3 study Enthalten in Clinical and experimental nephrology 20.2.2025: 1-13
|
|